How to invest in Techemy Capital’s non-custodial portfolios on Enzyme

Techemy Capital has launched two actively managed portfolios that allow investors to gain exposure to BTC/ETH price action and the DeFi sector. Trades are executed by Techemy Capital’s Josh Olszewicz. Investors can take advantage of crypto price moves without having to trade themselves - and because Techemy’s products are non-custodial - without releasing control of their assets.
The link will open a new window. Click the menu and down arrow to download the file.
Podcasts available on
Guest:
Josh Olszewicz
Why you should listen:
Trader Josh Olszewicz joins Andy to talk about the two actively managed portfolios that Techemy Capital has deployed on Enzyme Finance. Individuals can invest into the portfolios in a non-custodial manner that gives them exposure to Josh’s professional trading strategies.
Key takeaway:
Enzyme Finance is an on-chain asset management platform. Because everything is on-chain all trades are transparent and recorded on the blockchain. Rather than have to learn the stress of trading themselves, investors can simply buy into either portfolio and capture the gains or losses that the portfolios achieve over time. Investors can enter or leave the portfolios at any time.
Supporting links:
If you enjoyed the show please subscribe to the Crypto Conversation and give us a 5-star rating and a positive review in whatever podcast app you are using.
Disclaimer: Any educational content, market commentary, research, analysis, forecasts, coaching, training, or opinions provided by independent third parties do not represent the views of Plus500. Plus500 provides self-trading execution-only services and does not provide asset management nor investment, financial, legal, or tax advice. Plus500 accepts no responsibility or liability for any decisions made or losses incurred as a result of reliance on information, research, educational materials, coaching, or services provided by third parties.





